CURE ACTIVE: Clopidogrel genotype and event rates | theheart.org
Links shared publicly online about this topic.
- 913total visits
CURE ACTIVE: Clopidogrel genotype and event rates | theheart.org
UPDATED WITH COMMENTARY // However, a gain-of-function genotype was associated with a greater benefit of clopidogrel in the CURE trial, but not the ACTIVE A trial.
View full resource at theheart.org
Tags: Drug, Anti-Clotting Medication, Plavix, Iscover
Most Recently Shared on August 29, 2010 at 7:45 pm By:
Lots of new gene-anti-platelet drug PGx new and conflicting data http://bit.ly/bw9h8Z and http://bit.ly/aAIVow
Also Shared By:
Advertisement
Shelley Wood
@theheartorg
#ESC10 - CURE ACTIVE: No effect of loss-of-function clopidogrel gene on event rates in ACS or AF http://www.theheart.org/article/1113971.do
1 year ago...